Matthew S Lamm

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Attention Deficit Hyperactivity Disorder

Top Venues

Molecular pharmaceutics

ACS applied bio materials

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaolong Zhu, Ashish Punia, Daniel Skomski, Yongchao Su, C Scott Shultz, Morgan B Giles, Nathan D Rudd, Nisha Raman, Athanas Koynov, Matthew S Lamm
Insights into Factors Affecting Ethylene-Vinyl Acetate Copolymer Crystallinity in Islatravir Implant. Molecular pharmaceutics 21 (4) (2024)
Xiaolong Zhu, Ashish Punia, Daniel Skomski, Yongchao Su, C Scott Shultz, Morgan B Giles, Nathan D Rudd, Nisha Raman, Athanas Koynov, Matthew S Lamm
Insights into Factors Affecting Ethylene-Vinyl Acetate Copolymer Crystallinity in Islatravir Implant. Molecular pharmaceutics 21 (4) (2024)
Elena J Di Mare, Ashish Punia, Matthew S Lamm, Timothy A Rhodes, Adam J Gormley
Data-Driven Design of Novel Polymer Excipients for Pharmaceutical Amorphous Solid Dispersions. Bioconjugate chemistry (2024)
Xiaolong Zhu, Ashish Punia, Daniel Skomski, Yongchao Su, C Scott Shultz, Morgan B Giles, Nathan D Rudd, Nisha Raman, Athanas Koynov, Matthew S Lamm
Insights into Factors Affecting Ethylene-Vinyl Acetate Copolymer Crystallinity in Islatravir Implant. Molecular pharmaceutics (2024)
Nathanael Sallada, Yongjun Li, Bryan W Berger, Matthew S Lamm
Engineered Hydrophobin as a Crystallization Inhibitor for Flufenamic Acid. ACS applied bio materials 4 (8) (2021)
Ashleigh N Bristol, Matthew S Lamm, Yongjun Li
Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation. Molecular pharmaceutics 18 (12) (2021)